Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: RavBruce who wrote (679)	4/9/1998 5:46:00 PM
From: Sonki	Read Replies (2) \| Respond to of 1580

Mabye weakness in mrk comes from this... I have been thinking about adding to my Mrk y Mrk a I was wondering does any one know what % Mrk's revenue comes from (aggrastat)??? ? COR stock jumps on FDA backing for heart drug Next week Merck & Co. is going before an FDA advisory panel with its Aggrastat d rug for unstable angina. mrk rise from 115 to 130 and COR dropped and now vice versa. ofcourse Mrk has so many other products so you don't feel the quite a movement like in COR quote.yahoo.com I tried to call Mrk IR Lou Jordon 908-423-1000 but something's wrong w. my phone, i am getting a fast busy signal. This info, incase some one wants to followup .... Need some inforative opinion before I add mrk at this level. Or how much further it might sink becasuse of this news? I know as a long term investor it should not matter but if if I can get MRK 10% lower that's 10% more in the pocket right? ANY KIND OF INFORMED OPINION WOULD BE GREATELY APPRICIATED thx in advance.